论文部分内容阅读
基本药物制度是医药卫生体系四大支柱之一,在这一轮医改中具有重要地位。基本药物制度发展的方向事关“看病难、看病贵”问题的解决,事关医药卫生事业的进步,事关医药产业的发展。中国药学会“基本药物制度研究”课题组,最近发布了《基本药物制度:理论和实践》报告,对基本药物制度的基本理论和国际实践经验进行了梳理,为我们研究和政策制定提供了一些依据。限于篇幅,本刊将分两期刊出该报告,并对报告的结构做了相应的调整。
The basic medicine system is one of the four pillars of the medical and health system and plays an important role in this round of medical reform. The direction of the development of the basic medicine system is related to the solution to the problem of “difficulty in seeing a doctor and expensive doctor”, which is related to the progress of the medical and health undertaking and is related to the development of the pharmaceutical industry. The Chinese Pharmaceutical Association “Research Group on Essential Drugs ” recently released the report “Basic Drug System: Theory and Practice”, sorted out the basic theory and international practical experience of the basic drug system and provided us with research and policy formulation Some basis. Due to space limitations, the journal will publish the report in two phases and make corresponding adjustments to the structure of the report.